Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Denali Therapeutics Inc (NASDAQ: DNLI) closed at $19.4 in the last session, up 1.41% from day before closing price of $19.13. In other words, the price has increased by $1.41 from its previous closing price. On the day, 0.98 million shares were traded. DNLI stock price reached its highest trading level at $19.575 during the session, while it also had its lowest trading level at $18.74.
Ratios:
We take a closer look at DNLI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.79 and its Current Ratio is at 9.79. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 12 ’25 when Schuth Alexander O. sold 2,937 shares for $13.58 per share. The transaction valued at 39,884 led to the insider holds 242,346 shares of the business.
Ho Carole sold 2,937 shares of DNLI for $39,884 on Aug 12 ’25. The Chief Medical Officer now owns 217,391 shares after completing the transaction at $13.58 per share. On Aug 13 ’25, another insider, Ho Carole, who serves as the Chief Medical Officer of the company, sold 806 shares for $14.64 each. As a result, the insider received 11,800 and left with 216,585 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNLI now has a Market Capitalization of 2845239552 and an Enterprise Value of 2041515520.
Stock Price History:
The Beta on a monthly basis for DNLI is 1.09, which has changed by -0.22399998 over the last 52 weeks, in comparison to a change of 0.12934029 over the same period for the S&P500. Over the past 52 weeks, DNLI has reached a high of $26.18, while it has fallen to a 52-week low of $10.57. The 50-Day Moving Average of the stock is 22.28%, while the 200-Day Moving Average is calculated to be 28.37%.
Shares Statistics:
According to the various share statistics, DNLI traded on average about 1.85M shares per day over the past 3-months and 1338960 shares per day over the past 10 days. A total of 146.63M shares are outstanding, with a floating share count of 130.46M. Insiders hold about 11.05% of the company’s shares, while institutions hold 95.07% stake in the company. Shares short for DNLI as of 1763078400 were 14017386 with a Short Ratio of 7.57, compared to 1760486400 on 14527782. Therefore, it implies a Short% of Shares Outstanding of 14017386 and a Short% of Float of 10.69.
